Pharmacological targeting of the TLR8/AP-1 axis ameliorates scleroderma skin inflammation and fibrosis by suppressing monocyte-mediated endothelial injury
Fuente:
Life Sciences
Publication date: 1 September 2026Source: Life Sciences, Volume 400Author(s): Xiangzhen Kong, Menghua Hu, Qiaorui Tan, Shuai Jiang, Shaohui Wang, Haiyan Chu, Qingmei Liu, Yanyun Ma, Jingyi Yang, Siyi Zhou, Jingzhen Lai, Min Du, Wenyu Wu, Lei Wang, Weilin Pu, Xiao Long, Jiucun Wang